Expected $0.79-per-share impact weighs on Procter & Gamble’s 2027 earnings growth
Key Facts
Procter & Gamble expects a combination of costs and financial conditions to reduce core earnings per share by $0.79 in fiscal 2027, equivalent to an 11% drag on its growth, according to a company filing. The impact combines pressures that extend beyond a single line item, while the company attributed cost pressure to higher raw material, energy and transportation prices. In the same filing, the company held its fiscal 2027 organic sales growth forecast at 1% to 3%. It also maintained its forecast for core earnings per share growth in a range from flat to 3%. The outlook sets sales growth against the expected impact of costs on earnings per share during the fiscal year.
In the first quarter of fiscal 2027, sales rose 4% to $23.28 billion, beating analysts’ estimates of $22.80 billion, according to Reuters. But revenue growth did not prevent core operating margin from declining 80 basis points in the quarter ended September 30, 2026. The decline came despite the company achieving total productivity savings of 250 basis points during the quarter. The comparison shows that the savings were not enough to prevent the core margin from contracting during the period. Sales beating estimates therefore coincided with pressure on operating profitability.
By component, total sales volume rose 2.4% in the three months through September 2026, while prices increased about 0.4%, according to Reuters. The figures reflect a greater contribution from volume than from prices to sales growth during that period. On costs, Chief Financial Officer Andre Schulten said pressure from higher commodity costs is expected to intensify over the next two quarters. That timing points to continued pressure on the company through the next half of its fiscal year, alongside its current annual outlook. The official filing did not announce specific price increases for the company’s products.
In trading, the company’s shares rose about 6% after the first-quarter results were announced on October 22, 2026, as the results beat expectations, according to Reuters. The share move that day was linked to the release of better-than-expected results, the coverage said. No verified data on the stock’s high or low in the October 30 session was included in the facts provided. Looking ahead, Schulten said commodity cost pressures would intensify over the next two quarters. The company’s forecasts for fiscal 2027 organic sales and core earnings growth remain within the ranges it held unchanged.